PULMONARY VASCULITIDES
- Authors: Kraeva V.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 23, No 2 (2012)
- Pages: 11
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115306
- ID: 115306
Cite item
Open Access
Access granted
Abstract
The paper analyzes the data available in the Russian and foreign literature on pulmonary vasculitides. Prominence is given to the pathogenesis and clinical course of different systemic vasculitides with lung involvement and to current regimens for their therapy.
Full Text
About the authors
V. Kraeva
I.M. Sechenov First Moscow State Medical University
Email: valentinakraeva@yandex.ru
References
- Бекетова Т. В. Перспективы применения ритуксимаба при васкулитах, ассоциированных с антинейтрофильными цитоплазматическими антителами // Научно-практич. ревматол. - 2010; 4 (1): 80-90.
- Семенкова Е. Н. Системные некротизирующие васкулиты. - М.: Русский врач, 2001. - 96 с.
- Соловьев., С. К. Современные представления об интенсивной терапии системной красной волчанки // Лечащий врач. - 2002; 3: 9-10.
- Brown K. Pulmonary vasculitis // Proc. Am. Thorac. Soc. - 2006; 3: 48-57.
- Chen M., Yu F., Zhang Y. et al. Antineutrophil cytoplasmic antibody-associated vasculitis in older patients // Medicine (Baltimore). - 2008; 87: 203-209.
- Chung M., Yi C., Lee H. et al. Imaging of pulmonary vasculitis // Radiology. -2010; 255 (2): 322-341.
- Erlich J., Sevastos J., Pussel B. Goodpasture’s disease: antiglomerular basement membrane disease // Nephrology. - 2004; 9: 49-51.
- Frankel S., Cosgrove G., Fischer A. et al. Update in the diagnosis and management of pulmonary vasculitis // Chest. - 2006; 129: 452-465.
- Gomez-Puerta J., Hernandez-Rodriguez J., Lopez-Soto A. et al. Antineutrophil cytoplasmatic antibody-associated vasculitides and respiratory disease // Chest. -2009; 136: 1101-1111.
- Holguin F., Ramadan B., Gal A. et al. Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis // Am. J. Med. Sci. - 2008; 336: 321-326.
- Jennette J., Falk R. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies // Curr. Opin. Rheumatol. - 2008; 20 (1): 55-60.
- Khan S., Subla M., Behl D. et al. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. // Chest. - 2007; 131: 972-976.
- Kwok S., Moon S., Ju J. et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea // Lupus. - 2011; 20: 102-107.
- Lara A., Schwarz M. Diffuse alveolar hemorrhage // Chest. - 2010; 137: 1164-1171.
- Luqmani R., Flossmann O. Outcome in small-vessel systemic vasculitis // J. Rheumatol. - 2006; 33: 1224-1227.
- Mukhtyar C., Guillevin L., Cid M. et al. EULAR recommendations for the management of primary small and medium vessel vasculitis // Ann. Rheum. Dis.-2009; 68:310-317.
- Pagnoux C., Guilpain P., Guillevin L. Churg-Strauss syndrome. Corr. Opin. Rheumatol. - 2007; 19: 25-32.
- Pagnoux C., Hogan S., Chin H. et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts // Artritis Rheum. - 2008; 58: 2908-2918.
- Papiris S., Manali E., Kalomenidis I. et al. Bench-to-bedside review: Pulmonary-renal syndromes - an update for the intensivist // Critical Care. - 2007; 11: 213.
- Polychronopoulos V., Prakash U., Golbin J., et al. Airway involvement in Wegener’s granulematosis // Rheum. Dis. Clin. North. Am. - 2007; 33: 755-775.
- Stone J. Wegener’s Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s Granulomatosis Etanercept Trial // Arthritis. Rheum. - 2003; 48 (8): 2299-2309.
Supplementary files
